LONDON, June 23 /PRNewswire-FirstCall/ -- SkyePharma PLC announces today that the Company’s Chief Operating Officer, Dr. Ken Cunningham, will make a presentation at the Jefferies Life Sciences Conference on Tuesday, June 27th, 2006 at 9:30 a.m. (ET) at the Mandarin Oriental Hotel, New York.
Investors and other interested parties may access a live audio webcast along with the slides of this presentation on SkyePharma’s website http://www.skyepharma.com under the Investor Relations tab.
SkyePharma PLC develops pharmaceutical products benefiting from world-leading drug delivery technologies that provide easier-to-use and more effective drug formulations. There are now eleven approved and marketed products incorporating SkyePharma’s technologies in the areas of oral, injectable, inhaled and topical delivery, supported by advanced solubilisation capabilities. For more information, visit http://www.skyepharma.com .
For further information please contact: SkyePharma PLC +44 207 491 1777 Frank Condella, Chief Executive Officer Peter Laing, Director of Corporate Communications +44 207 491 5124 Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000 Tim Anderson / Rebecca Skye Dietrich
SkyePharma PLC
CONTACT: Frank Condella, Chief Executive Officer, +44-207-491-1777, orPeter Laing, Director of Corporate Communications, +44-207-491-5124, orSandra Haughton, US Investor Relations +1-212-753-5780, all of SkyePharmaPLC; or Tim Anderson or Rebecca Skye Dietrich, both of BuchananCommunications for SkyePharma PLC, +44-207-466-5000
Web site: http://www.skyepharma.com/
